Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vasculitis: Mepolizumab for eosinophilic granulomatosis with polyangiitis.

Literature DB >> 28769112

Vasculitis: Mepolizumab for eosinophilic granulomatosis with polyangiitis.

Loïc Guillevin¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2017 PMID： 28769112 DOI： 10.1038/nrrheum.2017.117

Source DB: PubMed Journal: Nat Rev Rheumatol ISSN： 1759-4790 Impact factor: 20.543

× No keyword cloud information.

8 in total

1. Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients.

Authors: Bogdan Jakiela; Wojciech Szczeklik; Hanna Plutecka; Barbara Sokolowska; Lucyna Mastalerz; Marek Sanak; Stanislawa Bazan-Socha; Andrzej Szczeklik; Jacek Musial
Journal: Rheumatology (Oxford) Date: 2012-07-05 Impact factor: 7.580

2. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.

Authors: Matthieu Groh; Christian Pagnoux; Chiara Baldini; Elisabeth Bel; Paolo Bottero; Vincent Cottin; Klaus Dalhoff; Bertrand Dunogué; Wolfgang Gross; Julia Holle; Marc Humbert; David Jayne; J Charles Jennette; Romain Lazor; Alfred Mahr; Peter A Merkel; Luc Mouthon; Renato Alberto Sinico; Ulrich Specks; Augusto Vaglio; Michael E Wechsler; Jean-François Cordier; Loïc Guillevin
Journal: Eur J Intern Med Date: 2015-05-09 Impact factor: 4.487

3. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome.

Authors: Régis Sablé-Fourtassou; Pascal Cohen; Alfred Mahr; Christian Pagnoux; Luc Mouthon; David Jayne; Daniel Blockmans; Jean-François Cordier; Philippe Delaval; Xavier Puechal; Dominique Lauque; Jean-François Viallard; Abdelkader Zoulim; Loïc Guillevin
Journal: Ann Intern Med Date: 2005-11-01 Impact factor: 25.391

Review 4. Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review.

Authors: Evelyn Sarnes; Leslie Crofford; Maria Watson; Greg Dennis; Hong Kan; Damon Bass
Journal: Clin Ther Date: 2011-10-13 Impact factor: 3.393

5. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.

Authors: Michael E Wechsler; Praveen Akuthota; David Jayne; Paneez Khoury; Amy Klion; Carol A Langford; Peter A Merkel; Frank Moosig; Ulrich Specks; Maria C Cid; Raashid Luqmani; Judith Brown; Stephen Mallett; Richard Philipson; Steve W Yancey; Jonathan Steinfeld; Peter F Weller; Gerald J Gleich
Journal: N Engl J Med Date: 2017-05-18 Impact factor: 91.245

6. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort.

Authors: Cloé Comarmond; Christian Pagnoux; Mehdi Khellaf; Jean-François Cordier; Mohamed Hamidou; Jean-François Viallard; François Maurier; Stéphane Jouneau; Boris Bienvenu; Xavier Puéchal; Olivier Aumaître; Guillaume Le Guenno; Alain Le Quellec; Ramiro Cevallos; Olivier Fain; Bertrand Godeau; Raphaèle Seror; Bertrand Dunogué; Alfred Mahr; Philippe Guilpain; Pascal Cohen; Achille Aouba; Luc Mouthon; Loïc Guillevin
Journal: Arthritis Rheum Date: 2013-01

Review 7. Eosinophils in vasculitis: characteristics and roles in pathogenesis.

Authors: Paneez Khoury; Peter C Grayson; Amy D Klion
Journal: Nat Rev Rheumatol Date: 2014-07-08 Impact factor: 20.543

8. Mepolizumab treatment in patients with severe eosinophilic asthma.

Authors: Hector G Ortega; Mark C Liu; Ian D Pavord; Guy G Brusselle; J Mark FitzGerald; Alfredo Chetta; Marc Humbert; Lynn E Katz; Oliver N Keene; Steven W Yancey; Pascal Chanez
Journal: N Engl J Med Date: 2014-09-08 Impact factor: 91.245